Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
CiplaMed is the specialized medical education and digital knowledge platform of Cipla, a leading global pharmaceutical company. It serves as a comprehensive resource for healthcare professionals, providing evidence-based medical information, clinical practice guidelines, and detailed product data. The platform covers a wide range of therapeutic areas, including respiratory, cardiology, urology, and infectious diseases, reflecting the core strengths of its parent company. CiplaMed offers various clinical tools, such as dosage calculators, journal summaries, and expert-led webinars, to support informed clinical decision-making. By bridging the gap between pharmaceutical innovation and clinical practice, the platform aims to enhance patient care standards globally. It is recognized for providing high-quality, peer-reviewed content tailored specifically for the medical community.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on CiplaMed.